[Implementing ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity]
- PMID: 7871610
- DOI: 10.1007/BF02588744
[Implementing ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity]
Abstract
Plaster cast immobilisation following trauma is a major risk factor for the development of deep vein thrombosis. In our controlled, randomized and prospective study in patients with minor injuries the incidence of deep vein thrombosis was 4.3% in conservatively treated outpatients with plaster cast immobilisation of the leg (n = 163 control group without prophylaxis). By application of low molecular weight heparin once daily the number of deep vein thrombosis in the prophylaxis group (n = 176) was reduced to 0% (p = 0.006). No severe side effects of low molecular weight heparin were observed. Subcutaneous injections were self-applicated by 89% of males and 72% of females. We conclude that thromboprophylaxis with low molecular weight heparin once daily is effective to reduce the risk of deep vein thrombosis in outpatients with plaster cast immobilisation of the leg.
Similar articles
-
[Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity].Chirurg. 1993 Jun;64(6):483-91. Chirurg. 1993. PMID: 8395380 Clinical Trial. German.
-
Thromboprophylaxis with low-molecular-weight heparin in outpatients with plaster-cast immobilisation of the leg.Lancet. 1995 Aug 19;346(8973):459-61. doi: 10.1016/s0140-6736(95)91320-3. Lancet. 1995. PMID: 7637478 Clinical Trial.
-
[Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity].Vasa Suppl. 1992;35:105-6. Vasa Suppl. 1992. PMID: 1336215 Clinical Trial. German. No abstract available.
-
Outpatient treatment of deep vein thrombosis with LMWH.Wien Med Wochenschr. 1999;149(2-4):46-9; discussion 49. Wien Med Wochenschr. 1999. PMID: 10378322 Review.
-
Treatment of deep vein thrombosis (DVT) with low molecular weight heparins (LMWH).Adv Exp Med Biol. 1992;313:275-81. doi: 10.1007/978-1-4899-2444-5_27. Adv Exp Med Biol. 1992. PMID: 1332441 Review. No abstract available.
Cited by
-
Insufficient Evidence for Routine Use of Thromboprophylaxis in Ambulatory Patients with an Isolated Lower Leg Injury Requiring Immobilization: Results of a Meta-Analysis.Eur J Trauma Emerg Surg. 2009 Apr;35(2):169-75. doi: 10.1007/s00068-008-8015-y. Epub 2008 Dec 8. Eur J Trauma Emerg Surg. 2009. PMID: 26814772
-
[Compliance of patients undergoing thromboprophylaxis with enoxaparin: the COMFORT study].Chirurg. 2013 Mar;84(3):235-42. doi: 10.1007/s00104-012-2443-2. Chirurg. 2013. PMID: 23404249 German.
-
Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-limb immobilization.Cochrane Database Syst Rev. 2017 Aug 6;8(8):CD006681. doi: 10.1002/14651858.CD006681.pub4. Cochrane Database Syst Rev. 2017. PMID: 28780771 Free PMC article.
-
[Heparin-induced thrombocytopenia type II (HIT II) : A medical-economic view].Med Klin Intensivmed Notfmed. 2017 May;112(4):334-346. doi: 10.1007/s00063-016-0237-x. Epub 2016 Dec 22. Med Klin Intensivmed Notfmed. 2017. PMID: 28005139 Review. German.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous